US7238707B2
(en)
|
2000-07-28 |
2007-07-03 |
Schering Ag |
Substituted pentanols, a process for their production and their use as anti-inflammatory agents
|
DE10346940B3
(en)
*
|
2003-10-06 |
2005-06-16 |
Schering Ag |
Substituted pentanols, their use for the preparation of medicaments, in particular anti-inflammatories and pharmaceutical compositions containing them
|
US6960581B2
(en)
|
2002-01-14 |
2005-11-01 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical formulations, and uses thereof
|
BR0308394A
(en)
*
|
2002-03-11 |
2005-01-25 |
Schering Ag |
5- {2-Hydroxy-3- [1- (3-trifluoromethylphenyl) -cyclopropyl] -propionylamino} -phthalide and progesterone receptor modulating activity-related compounds for use in fertility control and hormone replacement therapy
|
EP1344776A1
(en)
*
|
2002-03-11 |
2003-09-17 |
Schering Aktiengesellschaft |
5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders
|
RS51097B
(en)
|
2002-03-26 |
2010-10-31 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions,and uses thereof
|
JP2005521717A
(en)
|
2002-03-26 |
2005-07-21 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
Glucocorticoid mimetics, process for producing the same, pharmaceutical composition thereof, and use thereof
|
US6897224B2
(en)
*
|
2002-04-02 |
2005-05-24 |
Schering Ag |
Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
|
DE10215316C1
(en)
*
|
2002-04-02 |
2003-12-18 |
Schering Ag |
Quinoline and isoquinoline derivatives, a pharmaceutical agent and their use as anti-inflammatory agents
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
AU2003259747A1
(en)
|
2002-08-21 |
2004-03-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
ATE473740T1
(en)
*
|
2002-08-29 |
2010-07-15 |
Boehringer Ingelheim Pharma |
3-(SULFONAMIDOETHYL)-INDOLE DERIVATIVES FOR USE AS GLUCOCORTICOID MIMETICS IN THE TREATMENT OF INFLAMMATORY, ALLERGIC AND PROLIFERATIVE DISEASES
|
CA2512257A1
(en)
|
2003-01-03 |
2004-07-29 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
|
WO2004071389A2
(en)
*
|
2003-02-15 |
2004-08-26 |
Glaxo Group Limited |
Non-steroidal infalmmation inhibitors
|
US20040224992A1
(en)
*
|
2003-02-27 |
2004-11-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
TW200519106A
(en)
|
2003-05-02 |
2005-06-16 |
Novartis Ag |
Organic compounds
|
US20050090559A1
(en)
*
|
2003-07-01 |
2005-04-28 |
Markus Berger |
Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents
|
WO2005003098A1
(en)
*
|
2003-07-01 |
2005-01-13 |
Schering Aktiengesellschaft |
Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents
|
UY28526A1
(en)
|
2003-09-24 |
2005-04-29 |
Boehringer Ingelheim Pharma |
GLUCOCORTICOID MIMETICS, METHODS OF PREPARATION PHARMACEUTICAL COMPOSITIONS AND USES OF THE SAME
|
DE10347385A1
(en)
|
2003-10-08 |
2005-05-12 |
Schering Ag |
Rearranged pentanols, a process for their preparation and their use as anti-inflammatory agents
|
DE102004017662B3
(en)
*
|
2004-04-05 |
2005-12-08 |
Schering Ag |
New 1-amino-tetrahydronaphthalene derivatives, useful for treatment of e.g. inflammation, bind with high selectivity to glucocorticoid receptors
|
PL1670458T3
(en)
|
2003-10-08 |
2007-05-31 |
Bayer Schering Pharma Ag |
1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
|
US7638515B2
(en)
|
2003-10-08 |
2009-12-29 |
Bayer Schering Pharma Aktiengesellschaft |
Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
|
US7662821B2
(en)
|
2003-10-08 |
2010-02-16 |
Bayer Schering Pharma Ag |
Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
|
ATE366726T1
(en)
|
2003-10-16 |
2007-08-15 |
Boehringer Ingelheim Pharma |
STEREOSELECTIVE SYNTHESIS OF CERTAIN TRIFLUOROMETHYL-SUBSTITUTED ALCOHOLS
|
GB0401334D0
(en)
|
2004-01-21 |
2004-02-25 |
Novartis Ag |
Organic compounds
|
US7795272B2
(en)
|
2004-03-13 |
2010-09-14 |
Boehringer Ingelheim Pharmaceutical, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
|
US20080153859A1
(en)
|
2004-04-05 |
2008-06-26 |
Hartmut Rehwinkel |
Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
|
GB0411056D0
(en)
|
2004-05-18 |
2004-06-23 |
Novartis Ag |
Organic compounds
|
WO2006000401A1
(en)
*
|
2004-06-28 |
2006-01-05 |
Glaxo Group Limited |
Substituted oxazines as glucocorticoid receptor modulators
|
WO2006000398A1
(en)
*
|
2004-06-28 |
2006-01-05 |
Glaxo Group Limited |
2,3-benzoxazin derivatives as non-steroidal glucocorticoid receptor modulators
|
GB0418045D0
(en)
|
2004-08-12 |
2004-09-15 |
Glaxo Group Ltd |
Compounds
|
DE102004044680B3
(en)
*
|
2004-09-09 |
2006-06-08 |
Schering Ag |
Alkylidene tetrahydronaphthalene derivatives, process for their preparation and their use as anti-inflammatory agents and pharmaceutical compositions containing them
|
US20060084652A1
(en)
*
|
2004-09-09 |
2006-04-20 |
Stefan Baeurle |
Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
|
GT200500281A
(en)
|
2004-10-22 |
2006-04-24 |
Novartis Ag |
ORGANIC COMPOUNDS.
|
GB0424284D0
(en)
|
2004-11-02 |
2004-12-01 |
Novartis Ag |
Organic compounds
|
GB0426164D0
(en)
|
2004-11-29 |
2004-12-29 |
Novartis Ag |
Organic compounds
|
US20060167025A1
(en)
*
|
2004-12-22 |
2006-07-27 |
Markus Berger |
Tricyclic amino alcohols, processes for synthesis of same and use of same as anti-inflammatory drugs
|
DE102004063227A1
(en)
*
|
2004-12-22 |
2006-07-06 |
Schering Ag |
Tricylic amino alcohols, process for their preparation and their use as anti-inflammatory agents
|
PE20060776A1
(en)
*
|
2004-12-27 |
2006-09-26 |
Boehringer Ingelheim Pharma |
MIMETICS OF GLUCOCORTICOIDES, METHODS TO PREPARE THEM AND PHARMACEUTICAL COMPOSITIONS
|
JP2006213674A
(en)
*
|
2005-02-07 |
2006-08-17 |
Ube Ind Ltd |
Method for preparing 4-formyltetrahydropyran compound
|
US20060229305A1
(en)
*
|
2005-03-22 |
2006-10-12 |
Markus Berger |
Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
|
DE102005014089A1
(en)
*
|
2005-03-22 |
2006-09-28 |
Schering Ag |
Tetrahydronaphthalene derivatives, process for their preparation and their use as anti-inflammatory agents
|
JP2006265173A
(en)
*
|
2005-03-24 |
2006-10-05 |
Sumitomo Chemical Co Ltd |
Crystal comprising complex of glucocorticoid receptor ligand connecting domain with ligand
|
DE102005017301A1
(en)
*
|
2005-04-14 |
2006-10-19 |
Schering Ag |
Substituted chroman derivatives, process for their preparation and their use as anti-inflammatory agents
|
DE102005017326A1
(en)
*
|
2005-04-14 |
2007-03-29 |
Schering Ag |
Tetrahydronaphthalene derivatives, process for their preparation and their use as anti-inflammatory agents
|
DE102005018026B4
(en)
*
|
2005-04-14 |
2006-12-21 |
Schering Ag |
Substituted styrenes, process for their preparation and their use as anti-inflammatory agents
|
DE102005017286B3
(en)
*
|
2005-04-14 |
2006-12-28 |
Schering Ag |
Tetrahydronaphthalene derivatives, process for their preparation and their use as anti-inflammatory agents
|
GB0507577D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
JP2008540337A
(en)
|
2005-04-29 |
2008-11-20 |
ワイス |
Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
US7408060B2
(en)
*
|
2005-06-24 |
2008-08-05 |
Schering Ag |
Nonsteroidal progesterone receptor modulators
|
PT2532679T
(en)
|
2005-10-21 |
2017-07-18 |
Novartis Ag |
Human antibodies against il13 and therapeutic uses
|
JP4980366B2
(en)
*
|
2005-12-09 |
2012-07-18 |
エフ.ホフマン−ラ ロシュ アーゲー |
Glucocorticoid receptor modulators as anti-inflammatory agents
|
BRPI0619519A2
(en)
*
|
2005-12-09 |
2011-10-04 |
Hoffmann La Roche |
propionamide compounds as anti-inflammatory agents
|
GB0526244D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
GB0601951D0
(en)
|
2006-01-31 |
2006-03-15 |
Novartis Ag |
Organic compounds
|
EP1834948A1
(en)
|
2006-03-15 |
2007-09-19 |
Bayer Schering Pharma Aktiengesellschaft |
Tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiinflammatory drugs
|
KR20090003349A
(en)
*
|
2006-04-20 |
2009-01-09 |
글락소 그룹 리미티드 |
Novel compounds
|
SI2013211T1
(en)
|
2006-04-21 |
2012-07-31 |
Novartis Ag |
Purine derivatives for use as adenosin a2a receptor agonists
|
US7390772B2
(en)
*
|
2006-05-18 |
2008-06-24 |
International Flavor & Fragrances Inc. |
1-phenyl-spiro[2.5]octane-1-carbonitrile analogues their use in fragrance formulations
|
EP1878717A1
(en)
|
2006-07-14 |
2008-01-16 |
Bayer Schering Pharma Aktiengesellschaft |
Benzyl amines, a process for their production and their use as anti-inflammatory agents
|
EP2081933B1
(en)
|
2006-09-29 |
2011-03-23 |
Novartis AG |
Pyrazolopyrimidines as pi3k lipid kinase inhibitors
|
KR20090097908A
(en)
|
2006-12-06 |
2009-09-16 |
베링거 인겔하임 인터내셔날 게엠베하 |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
UY30805A1
(en)
*
|
2006-12-21 |
2008-07-31 |
Bayer Schering Pharma Ag |
NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS
|
PL2104535T3
(en)
|
2007-01-10 |
2011-05-31 |
Irm Llc |
Compounds and compositions as channel activating protease inhibitors
|
EP1958934A1
(en)
*
|
2007-02-16 |
2008-08-20 |
Bayer Schering Pharma Aktiengesellschaft |
Tetrahydronaphthalenylamides, a process for their production and their use as anti-inflammatory agents
|
KR20100005730A
(en)
|
2007-05-07 |
2010-01-15 |
노파르티스 아게 |
Organic compounds
|
JP4827986B2
(en)
|
2007-06-08 |
2011-11-30 |
マンカインド コーポレ−ション |
IRE-1α inhibitor
|
EP2062880A1
(en)
|
2007-11-22 |
2009-05-27 |
Bayer Schering Pharma Aktiengesellschaft |
5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
|
DE102007058747A1
(en)
*
|
2007-12-05 |
2009-06-10 |
Bayer Schering Pharma Aktiengesellschaft |
Nonsteroidal progesterone receptor modulators
|
EA017919B1
(en)
|
2007-12-10 |
2013-04-30 |
Новартис Аг |
Pyrazine-2 carboxamide derivatives for treating diseases which respond to the blocade of the epithelial sodium channels
|
WO2009087224A1
(en)
|
2008-01-11 |
2009-07-16 |
Novartis Ag |
Pyrimidines as kinase inhibitors
|
CN102112476A
(en)
|
2008-06-06 |
2011-06-29 |
贝林格尔.英格海姆国际有限公司 |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
CN102112130A
(en)
|
2008-06-10 |
2011-06-29 |
诺瓦提斯公司 |
Pyrazine derivatives as epithelial sodium channel blockers
|
EP2149558A1
(en)
|
2008-07-21 |
2010-02-03 |
Bayer Schering Pharma Aktiengesellschaft |
5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino-1-arylquinolin-2-ones, a process for their production and their use as anti-inflammatory agents
|
US8236786B2
(en)
|
2008-08-07 |
2012-08-07 |
Pulmagen Therapeutics (Inflammation) Limited |
Respiratory disease treatment
|
PL2379507T3
(en)
|
2008-12-30 |
2014-03-31 |
Pulmagen Therapeutics Inflammation Ltd |
Sulfonamide compounds for the treatment of respiratory disorders
|
SI2391366T1
(en)
|
2009-01-29 |
2013-01-31 |
Novartis Ag |
Substituted benzimidazoles for the treatment of astrocytomas
|
WO2010150014A1
(en)
|
2009-06-24 |
2010-12-29 |
Pulmagen Therapeutics (Inflammation) Limited |
5r- 5 -deuterated glitazones for respiratory disease treatment
|
JP2013500962A
(en)
|
2009-07-31 |
2013-01-10 |
カディラ ヘルスケア リミティド |
Novel compounds as modulators of glucocorticoid receptors
|
US8389526B2
(en)
|
2009-08-07 |
2013-03-05 |
Novartis Ag |
3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
|
AU2010283806A1
(en)
|
2009-08-12 |
2012-03-01 |
Novartis Ag |
Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation
|
SI2467141T1
(en)
|
2009-08-17 |
2019-03-29 |
Intellikine, Llc |
Heterocyclic compounds and uses thereof
|
IN2012DN01453A
(en)
|
2009-08-20 |
2015-06-05 |
Novartis Ag |
|
CN102665715A
(en)
|
2009-10-22 |
2012-09-12 |
沃泰克斯药物股份有限公司 |
Compositions for treatment of cystic fibrosis and other chronic diseases
|
US8247436B2
(en)
|
2010-03-19 |
2012-08-21 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF
|
US10130697B2
(en)
|
2010-03-23 |
2018-11-20 |
Wisconsin Alumni Research Foundation (Warf) |
Vaccines comprising mutant attenuated influenza viruses
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
US8637516B2
(en)
|
2010-09-09 |
2014-01-28 |
Irm Llc |
Compounds and compositions as TRK inhibitors
|
US8372845B2
(en)
|
2010-09-17 |
2013-02-12 |
Novartis Ag |
Pyrazine derivatives as enac blockers
|
WO2012107500A1
(en)
|
2011-02-10 |
2012-08-16 |
Novartis Ag |
[1, 2, 4] triazolo [4, 3 -b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
|
JP5808826B2
(en)
|
2011-02-23 |
2015-11-10 |
インテリカイン, エルエルシー |
Heterocyclic compounds and uses thereof
|
AP2013007103A0
(en)
|
2011-02-25 |
2013-09-30 |
Irm Llc |
Compounds and compositions as TRK inhibitors
|
US8883819B2
(en)
|
2011-09-01 |
2014-11-11 |
Irm Llc |
Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
|
UY34329A
(en)
|
2011-09-15 |
2013-04-30 |
Novartis Ag |
TRIAZOLOPIRIDINE COMPOUNDS
|
WO2013038381A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine/pyrazine amide derivatives
|
WO2013038378A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
ES2558457T3
(en)
|
2011-09-16 |
2016-02-04 |
Novartis Ag |
Heterocyclic compounds for the treatment of cystic fibrosis
|
US9056867B2
(en)
|
2011-09-16 |
2015-06-16 |
Novartis Ag |
N-substituted heterocyclyl carboxamides
|
WO2013038373A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
US9174994B2
(en)
|
2011-11-23 |
2015-11-03 |
Intellikine, Llc |
Enhanced treatment regimens using mTor inhibitors
|
US8809340B2
(en)
|
2012-03-19 |
2014-08-19 |
Novartis Ag |
Crystalline form
|
EP2834246B1
(en)
|
2012-04-03 |
2021-07-28 |
Novartis AG |
Combination products with tyrosine kinase inhibitors and their use
|
RU2483723C1
(en)
*
|
2012-04-25 |
2013-06-10 |
Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения и социального развития Российской Федерации |
Method of treating endocrine ophthalmopathy
|
US9073921B2
(en)
|
2013-03-01 |
2015-07-07 |
Novartis Ag |
Salt forms of bicyclic heterocyclic derivatives
|
CA2906542A1
(en)
|
2013-03-15 |
2014-09-25 |
Intellikine, Llc |
Combination of kinase inhibitors and uses thereof
|
WO2014198909A1
(en)
|
2013-06-14 |
2014-12-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Rac1 inhibitors for inducing bronchodilation
|
TW201605450A
(en)
|
2013-12-03 |
2016-02-16 |
諾華公司 |
Combination of Mdm2 inhibitor and BRAF inhibitor and their use
|
CA2945069A1
(en)
|
2014-04-24 |
2015-10-29 |
Novartis Ag |
Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors
|
MX2016013812A
(en)
|
2014-04-24 |
2017-03-09 |
Novartis Ag |
Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors.
|
WO2015162461A1
(en)
|
2014-04-24 |
2015-10-29 |
Novartis Ag |
Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
|
WO2015196150A2
(en)
|
2014-06-20 |
2015-12-23 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
WO2016011658A1
(en)
|
2014-07-25 |
2016-01-28 |
Novartis Ag |
Combination therapy
|
MX2017001461A
(en)
|
2014-07-31 |
2017-05-11 |
Novartis Ag |
Combination therapy.
|
CA2977591A1
(en)
|
2015-03-02 |
2016-09-09 |
Corcept Therapeutics, Inc. |
Use of glucocorticoid receptor antagonist and somatostatin analogues to treat acth-secreting tumors
|
ES2906778T3
(en)
|
2015-03-30 |
2022-04-20 |
Corcept Therapeutics Inc |
Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
|
MX2018001803A
(en)
|
2015-08-13 |
2018-05-16 |
Corcept Therapeutics Inc |
Method for differentially diagnosing acth-dependent cushing's syndrome.
|
JP6765443B2
(en)
|
2016-01-19 |
2020-10-07 |
コーセプト セラピューティクス, インコーポレイテッド |
Differential diagnosis of ectopic Cushing's syndrome
|
WO2018236749A2
(en)
|
2017-06-20 |
2018-12-27 |
Corcept Therapeutics, Inc. |
Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators
|
EP3569228A1
(en)
*
|
2018-05-17 |
2019-11-20 |
Association pour la recherche à l'IGBMC (ARI) |
Non-steroidal selective glucocorticoid receptor agonistic modulators (segrams) and uses thereof
|
ES2932076T3
(en)
*
|
2017-10-27 |
2023-01-11 |
Association Pour La Rech A Ligbmc Ari |
Nonsteroidal Selective Glucocorticoid Receptor Agonist Modulators (SEGRAMs) and Uses Thereof
|
US11851648B2
(en)
|
2019-02-08 |
2023-12-26 |
Wisconsin Alumni Research Foundation (Warf) |
Humanized cell line
|
MX2021015133A
(en)
|
2019-06-10 |
2022-01-24 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of cf, copd, and bronchiectasis.
|
WO2021041624A2
(en)
|
2019-08-27 |
2021-03-04 |
Yoshihiro Kawaoka |
Recombinant influenza viruses with stabilized ha for replication in eggs
|
MX2022002374A
(en)
|
2019-08-28 |
2022-03-29 |
Novartis Ag |
Substituted 1,3-phenyl heteroaryl derivatives and their use in the treatment of disease.
|
TW202140550A
(en)
|
2020-01-29 |
2021-11-01 |
瑞士商諾華公司 |
Methods of treating an inflammatory or obstructive airway disease using anti-tslp antibody
|
JP2024500748A
(en)
|
2020-12-18 |
2024-01-10 |
インスティル バイオ (ユーケイ) リミテッド |
Treatment of tumor-infiltrating lymphocytes
|